Letters: End the false economy of generic prescribing

The warning of adverse events linked to the use of generic drug alendronate in your article 'Side-effects of NICE-backed drug "wipe out cost savings"' (GP, 19 September) comes from a consultant physician.

It seems that NICE is not nice nor a patient-friendly regulatory body any more.

The UK is adapting policy to save money at the expense of patients' misery. Surely NICE can find a sensible alternative to this ridiculous false economy.

GPs are all too well aware of the adverse effects patients suffer from not only generic alendronate, but also many other cheap products pushed into the system. The incentive scheme is a failure and it is about time we reverted to prescribing branded, clean and well-tested pharmaceutical products ethically.

Dr Hari Nawal, Bedford.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Locum GPs 'sucked up' by private sector as COVID-19 hits income

Locum GPs 'sucked up' by private sector as COVID-19 hits income

Locum GPs have been 'sucked up' by private sector healthcare providers as the COVID-19...

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs have demanded urgent action to prevent avoidable harm to patients from the NHS...

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

GP practices will be unable to cope with a second wave of COVID-19 unless urgent...

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Dr Vasu Siva explains how her practice is aiming to cut its carbon emissions by targeting...

RCGP chair warns of 'significant problem' over flu vaccine supplies

RCGP chair warns of 'significant problem' over flu vaccine supplies

The NHS faces a 'significant problem' with flu vaccine supplies as it aims to cover...

GMC overhauls consent advice to improve patient involvement in decisions about care

GMC overhauls consent advice to improve patient involvement in decisions about care

The GMC has overhauled its guidance on patient consent - setting out seven key principles...